Capital Group Investment Management’s Ingersoll Rand IR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
16,159
-6,793
-30% -$526K 0.2% 99
2026
Q1
$1.84M Sell
22,952
-17,837
-44% -$1.58M 0.31% 87
2025
Q4
$3.23M Sell
40,789
-5,496
-12% -$434K 0.52% 55
2025
Q3
$3.82M Buy
46,285
+14,588
+46% +$1.2M 0.64% 46
2025
Q2
$2.64M Buy
31,697
+1,668
+6% +$131K 0.47% 63
2025
Q1
$2.4M Buy
30,029
+3,607
+14% +$314K 0.49% 63
2024
Q4
$2.39M Buy
26,422
+387
+1% +$38.5K 0.45% 64
2024
Q3
$2.56M Buy
26,035
+393
+2% +$36.5K 0.51% 62
2024
Q2
$2.33M Sell
25,642
-12,980
-34% -$1.19M 0.5% 61
2024
Q1
$3.67M Buy
38,622
+25,163
+187% +$2.15M 0.66% 42
2023
Q4
$1.04M Buy
13,459
+2,576
+24% +$176K 0.11% 145
2023
Q3
$693K Buy
+10,883
New +$724K 0.05% 159

Other funds holding IR

Capital Group Investment Management's IR Position: Q2 2026 in Review

Capital Group Investment Management reduced its Ingersoll Rand (IR) stake by 30% in Q2 2026, selling an estimated $526K and leaving 16,159 shares worth $1.32M. The position accounts for 0.2% of the portfolio, ranked #99.

Capital Group Investment Management first reported a position in IR in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.82M in Q3 2025. 892 funds tracked by Wall St. Rank hold IR as of Q2 2026.

  • Capital Group Investment Management held 16,159 shares of Ingersoll Rand worth $1.32M as of Q2 2026.
  • Capital Group Investment Management sold 6,793 Ingersoll Rand shares in Q2 2026, an estimated $526K.
  • Ingersoll Rand made up 0.2% of Capital Group Investment Management's portfolio in Q2 2026, its #99 holding.
  • Capital Group Investment Management first reported a position in Ingersoll Rand in Q3 2023 and has held it in 12 quarters since.
  • Capital Group Investment Management's Ingersoll Rand position peaked at $3.82M in Q3 2025.
  • 892 funds tracked by Wall St. Rank held Ingersoll Rand as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.